Subsequent analysis found that EV EpCAM signal differed between healthy controls and PDAC patients with any histologic grade, tumor stage or degree of lymph node involvement, but was not significantly different among different levels of any of these tumor parameters (Figures 4D–F). This evidence concerns the gene EPCAM and neoplasm.